Nyumbani › Leukemia ya Lymphoblastic ya Ghafla › Connecticut › New Haven
Majaribio ya kliniki ya Leukemia ya Lymphoblastic ya Ghafla katika New Haven, CT
Masomo 3 ya Leukemia ya Lymphoblastic ya Ghafla yanatafuta washiriki katika vituo vya New Haven na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
InaajiriHatua 1/2
- Yale University, New Haven
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
InaajiriUtafiti wa uchunguzi
- Yale New Haven Hospital, New Haven
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
InaajiriUtafiti wa uchunguzi
- Yale University, New Haven
Majaribio ya Leukemia ya Lymphoblastic ya Ghafla katika miji mingine
- Houston, TXUtafiti 28
- New York City, NYUtafiti 24
- Baldwin Park, CAUtafiti 21
- Seattle, WAUtafiti 21
- Chicago, ILUtafiti 19
- Atlanta, GAUtafiti 19
- Memphis, TNUtafiti 16
- Philadelphia, PAUtafiti 16
- Washington, DCUtafiti 16
- Boston, MAUtafiti 15
- Los Angeles, CAUtafiti 14
- Durham, NCUtafiti 13
Masomo mengine katika New Haven
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 41
- Saratani ya MatitiUtafiti 37
- Saratani (aina zote)Utafiti 33
- Saratani ya MetastasiUtafiti 23
- Saratan ya MapafuUtafiti 22
- Kansari ya Seluli za Skwamu za Kichwa na ShingoUtafiti 22
- Kansari ya MayaiUtafiti 21
- Kansari ya kolorektaliUtafiti 20
- Saratani ya ProstateUtafiti 20
- Dozi Kubwa ya OpioidUtafiti 18
- Kitu cha Kutumia Alcoholi (AUD)Utafiti 17
- Leukemia ya Myeloid ya GhaflaUtafiti 17
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.